Incontinent urinary diversion [PDF]
, 1991 1)膀胱癌に対する膀胱全摘除術時に尿路変更として, 回腸導管を188例に, 尿管瘻を49例に行った.2)術後30日以内の死亡はなかった.3)術後の早期合併症は, 回腸導管94, 尿管瘻18, 晩期合併症は, 回腸導管85, 尿管瘻23に認められた.合併症を認めなかったのは, 回腸導管49, 尿管瘻14であった.4)回腸導管の術後早期合併症は, 創感染(29%), 消化管疾患(13%), 上部尿路疾患(12%)が多くみられ, 晩期合併症は, ストーマの異常(26%), 上部尿路疾患(14%), 肝炎(13%
三木, 恒治 +6 more
core
Zhongguo shiyan zhenduanxue膀胱癌具有较高的发病率和死亡率[1]。目前临床上膀胱癌最可靠的诊断方法是膀胱镜检查，但这种侵入性检查容易造成微小肿瘤病灶的漏诊[2]。随着液相色谱-质谱联用（LC-MS/MS）技术的广泛应用，寻找诊断膀胱癌的蛋白标志物有了可能。本实验采用LC-MS/MS技术，研究钙磷蛋白（Calcyphosine, CAPS）在膀胱癌患者尿液中的表达水平，旨在为膀胱癌筛查提供一种新的方法。
薛菲, 李婷淼, 岳斯琦, 何成彦
doaj
Construction of a prediction model for prognosis of bladder cancer based on the expression of ion channel-related genes. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023 Zhang D, Yin G, Zheng S, Chen Q, Li Y.
europepmc +1 more source
Effect of Prophylactic Intravesical Instillation of BCG for Superficial Bladder Cancer [PDF]
, 2009 Between January 1997 and February 2005, a total of 106 patients with superficial bladder cancer were treated with transurethral resection of bladder tumor followed by intravesical instillation of Tokyo 172 strain bacillus Calmette-Guerin (BCG) once a ...
伊夫貴, 直和 +5 more
core
[Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2023 Liu HR, Peng X, Li SL, Gou X.
europepmc +1 more source
Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023 Xu C, Chen A, Mao C, Cui B.
europepmc +1 more source
[SLC12A8 promotes proliferation, invasiveness, migration and epithelial-mesenchymal transition of bladder cancer cells by activating JAK/STAT singaling]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2023 Zhang X, Wu H, Wang S.
europepmc +1 more source
A case of pneumocystis carinii pneumonia after chemotherapy of bladder tumor [PDF]
, 1985 This is a case report on a 70-year-old male patient. During chemotherapy treatment after a bladder tumor operation, the patient had a complication of pneumonia which did not respond to various antibiotics.
佐々木, 進 +3 more
core
负性共刺激分子PD-L1在非肌层浸润性膀胱癌的表达 及其对术后膀胱灌注治疗的影响
Zhongshan Daxue xuebao. Yixue kexue ban, 2015 【目的】 探讨负性共刺激分子PD-L1在非肌层浸润性膀胱癌的表达及其对术后膀胱灌注治疗的影响? 【方法】采用免疫组化法染色方法检测131例膀胱癌组织标本(均经病理诊断确认为非肌层浸润性膀胱癌)和10例正常膀胱黏膜组织标本的PD-L1表达情况,所有膀胱癌患者术后均予表柔比星或沙培林膀胱灌注,详细记录肿瘤复发?进展的时间和预后情况?【结果】 PD-L1在正常膀胱黏膜组织不表达0(0/10),在非肌层浸润性膀胱癌组织阳性率为56.5%(74/131),P=0.000?PD-L1的表达与病理分期相关,pTa ...
doaj
Zhongguo shiyan zhenduanxue, 2020 目的研究生存蛋白(Survivin)在膀胱癌患者尿液脱落细胞中的表达及临床相关性。方法本文选取2016年9月-2018年9月在我院就诊的膀胱癌患者50例,分为膀胱癌组,选取同时期在我院就诊的膀胱良性病变患者20例,分为良性组,选取同一时期在我院健康体检的志愿者20例,分为正常组。尿液脱落细胞DNA提取,实时荧光定量PCR检测Survivin在尿液脱落细胞中的表达。结果膀胱癌组尿液脱落细胞中Survivin表达高于正常组和良性组,良性组尿液脱落细胞中Survivin表达高于正常组,具有统计学差异 ...
徐兰锋, 朱丹, 袁潮
doaj